IXICO is a digital healthcare company that produces innovative medical technologies which enable faster and more accurate diagnosis of neurological diseases such as dementia. IXICO works with many of the leading pharmaceutical companies providing clinical trial services and technology to evaluate imaging endpoints as part of their drug development pipelines. The company's innovative technologies help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes. IXICO clinical focus is predominantly dementia, we also support clinical studies for other disease areas in the field of neuro-degeneration.
IXICO pioneering medical image management and analysis products are used by the global pharmaceutical industry to select patients for clinical trials and to assess the safety and efficacy of drugs in development.